It’s 100 years since the discovery of insulin, the life-saving drug for people living with diabetes.
But today, more than half of those who need this marvellous medicine still can’t access it – either because it’s too expensive or unavailable. This means millions of people are risking serious complications and even death.
In this episode of Everyday Emergency, Amber Dowell reports on the challenges facing those diagnosed with Type 1 diabetes living through crises such as conflict, displacement or disaster.
We hear from Farah Haris, who was working to treat diabetic patients in the fallout of last year’s devastating Beirut explosion. We also speak to chronic disease expert Amulya Reddy on how MSF is finding innovative new ways to help patients and challenge the three “Big Pharma” corporations controlling the insulin market.